Tag: Nektar
The Surge of Nektar Therapeutics: Stock Skyrockets Over 15%
Summary: 1. Nektar Therapeutics' pipeline drug, rezpegaldesleukin, has shown promising results in a phase 2b study for atopic…
The Rise of Nektar Therapeutics: A 6% Surge in Stock Performance
Summary: 1. Nektar Therapeutics reported strong quarterly earnings with a 6% increase in share price, outperforming the S&P…